Diagnostics Are Essential, But How Can Companies Ensure A Fair Price?

Biotech and pharma are increasingly clear about one thing: They need diagnostics. But with prices suppressed, how have diagnostics companies proven their utility without going under?

Stethescope and balance sheet. Concept: Business of healthcare
(janews/Shutterstock)

More from Diagnostics

More from Market Access